Clinical Trials Browser

Phase 2 × Congenital Abnormalities × Arsenic Trioxide × Clear all

NCT01835288 2018-05-21

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute